Literature DB >> 33754225

Encouraging Outcomes Allow Patient-Guided Treatment Strategies for Stage I Pure Testicular Teratoma.

Fady J Baky1, Raj R Bhanvadia1, Rohit R Badia1, Solomon Woldu1, Aditya Bagrodia2.   

Abstract

Entities:  

Year:  2021        PMID： 33754225     DOI： 10.1245/s10434-021-09700-w

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  7 in total

1.  Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer.

Authors:  Adam C Calaway; Lawrence H Einhorn; Timothy A Masterson; Richard S Foster; Clint Cary
Journal:  Eur Urol       Date:  2019-06-04       Impact factor: 20.096

2.  Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.

Authors:  Gedske Daugaard; Maria Gry Gundgaard; Mette Saksø Mortensen; Mads Agerbæk; Niels Vilstrup Holm; Mikael Rørth; Hans von der Maase; Ib Jarle Christensen; Jakob Lauritsen
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

3.  Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline.

Authors:  Andrew Stephenson; Scott E Eggener; Eric B Bass; David M Chelnick; Siamak Daneshmand; Darren Feldman; Timothy Gilligan; Jose A Karam; Bradley Leibovich; Stanley L Liauw; Timothy A Masterson; Joshua J Meeks; Phillip M Pierorazio; Ritu Sharma; Joel Sheinfeld
Journal:  J Urol       Date:  2019-07-08       Impact factor: 7.450

Review 4.  Late relapse of nonseminomatous germ cell tumours.

Authors:  Jan Oldenburg; Sophie D Fosså
Journal:  BJU Int       Date:  2009-11       Impact factor: 5.588

5.  Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy.

Authors:  C Kollmannsberger; C Moore; K N Chi; N Murray; S Daneshmand; M Gleave; B Hayes-Lattin; C R Nichols
Journal:  Ann Oncol       Date:  2009-10-29       Impact factor: 32.976

Review 6.  Non-risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and Summary.

Authors:  Phillip Martin Pierorazio; Peter Albers; Peter C Black; Torgrim Tandstad; Axel Heidenreich; Nicola Nicolai; Craig Nichols
Journal:  Eur Urol       Date:  2018-01-12       Impact factor: 20.096

Review 7.  Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature.

Authors:  Christian Guido Ruf; Simon Krampe; Cord Matthies; Petra Anheuser; Tim Nestler; Jörg Simon; Hendrik Isbarn; Klaus Peter Dieckmann
Journal:  World J Surg Oncol       Date:  2020-09-24       Impact factor: 2.754
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.